ClinicalTrials.gg
Not yet recruitingNCT07451093Updated Aug 27, 2026

Epileptiform Potential of Fully Immersive Virtual Reality

An interventional study of Virtual Reality Headset, display off and Virtual Reality Headset, Display only in Epilepsy and Seizure, sponsored by Dartmouth-Hitchcock Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
13 Years and older
Sex
All
01

Study summary

The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are:

- does use of virtual reality headsets with hand controllers result in a higher risk of seizure compared to use of virtual reality headsets without hand controllers Participants will be asked to wear a virtual reality headset during continuous video EEG recording and EEG with be evaluated during three phases: with display turned off, with display turned on without hand controllers, and with display turned on with hand controllers.

02

Conditions studied

  • Epilepsy
  • Seizure

Keywords

  • Epilepsy
  • Seizure
  • Virtual Reality
  • VR
  • Reflex epilepsy
03

In context

Epilepsy

1,848 studies on the registry are indexed under Epilepsy; 422 are open to participants now.

This study's planned enrollment of 40 is below the median of 50 across 1,239 interventional studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 488 studies on the registry; 71 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 21 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • subjects with known or suspected diagnosis of epilepsy with interictal epileptiform discharges seen during current or prior EEG recording
  • Age greater than or equal to 13 years

Exclusion criteria

Exclusion Criteria:

  • Age less than 13 years (infants, children)
  • Pregnancy
  • Incarceration
  • Moderate-severe cognitive impairment
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Virtual Reality Arm

    Participants wear VR headset during video EEG recording for a total of 3 sessions, each lasting 15 minutes each.

    Other: Virtual Reality Headset, display off · Other: Virtual Reality Headset, Display only · Other: Virtual Reality Headset, Display and Hand Control

Interventions

  • OtherVirtual Reality Headset, display off

    15 minutes of EEG recording with VR headset worn, display turned off. This will act as a baseline for intervention 2 and 3

  • OtherVirtual Reality Headset, Display only

    15 minutes of EEG recording with VR headset worn, display turned on without access to hand controls.

  • OtherVirtual Reality Headset, Display and Hand Control

    15 minutes of EEG recording with VR headset worn, display turned on with access to hand controls

06

What researchers measure

Primary outcomes

  1. Change in prevalence of interictal epileptiform discharges

    Interictal epileptiform discharges are counted by two epilepsy trained neurologists. Number of discharges seen are compared between each intervention.

    Time frame: Three sessions, 15 minutes each

Other outcomes

  1. Seizure

    Detection of a clinical or electrographic seizure event occurring with any intervention

    Time frame: 3 trials, 15 minutes each

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07451093
Responsible party
Jared.E.Quast (Principal Investigator, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Mar 5, 2026
Start date
Dec 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Aug 27, 2026

Study contacts

Jared E Quast, MD
Contact
jared.e.quast@hitchcock.org
6033505104
Jared E Quast, MD
principal investigator · Dartmouth-Hitchcock Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion